semaglutide versus ozempic GLP-1 vs vs Wegovy vs Mounjaro Higher-Dose Semaglutide Injection Proves Mettle

While it is not known if semaglutide causes these tumors in humans, the risk is taken very seriously

PSM published this report on the same day that it was reported that Eli Lilly would no longer be partnering with Noom to sell Zepbound and Mounjaro

Interestingly enough, in 6-OHDA rats, the dual GLP-1/GIP agonist (DA5-CH), in addition to promoting the survival of dopaminergic neurons, was able to reduce the levels of monomer and oligomers of -synuclein, thus providing a wider neuroprotective effect [53]

In addition to excessive expenditure on health care, obesity also imposes costs in the form of lost productivity at work, mortality, and permanent disability

Four weeks at 0.25 mg is a small time investment that prevents a much worse experience down the road